Gene-sequencing tech developer partners with Institute for Systems Biology on research.
|
CEO Sohaib Abbasi puts the company back in favor with investors.
|
Microsoft partners with pharma and biotech companies to accelerate drug development.
|
Pfizer takes a 12 percent stake in the Californian genotyping company.
|
Researchers employ technology used in emailing to solve a well-known problem in detecting gene activation.
|
Perlegen Sciences may have a shortcut to developing drugs.
|
Laboratory tool and reagent company Affymetrix acquires ParAllele Bioscience for $120 million.
|
Agencourt Bioscience bets on the lucrative next phase of genomics, which will set the stage for a healthcare 360°.
|